Pre-order Enquiry
Request Free Sample
Global Recombinant Human Serum Albumin Market Outlook 2022
SKU ID : QYR-19856572 | Publishing Date : 05-Jan-2022 | No. of pages : 103
Recombinant Human Serum Albumin (Rec. HSA) is animal origin free expressed in E.coli without animal or human derived raw materials. It is also free from other contaminating serum proteins.
Recombinant human serum albumin (rHSA) is genetically engineered and derived from a rice-based expression system. It is a highly purified and completely animal-, virus-, and bacteria-free product that was developed as an alternative to plasma-derived HSA, to which it is structurally equivalent.
Global Recombinant Human Serum Albumin key players include Albumedix, Merck, Ventria (InVitria), NCPC, Oryzogen, etc. Global top five manufacturers hold a revenue sales market share over 80%. Europe accounts for the most Market Share, which have a share over 45%, followed by North America. In terms of product, ScrHSA is the largest segment, with a share of 100% . And in terms of application, the largest application is Cell Culture Media, followed by Medical Supplements.
The global Recombinant Human Serum Albumin market was valued at US$ 65 million in 2020 and is expected to reach US$ 106.8 million by the end of 2027, growing at a CAGR of 7.3% during 2021-2027.
This report focuses on Recombinant Human Serum Albumin volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Recombinant Human Serum Albumin market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Recombinant Human Serum Albumin Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
OsrHSA
ScrHSA
Segment by Application
Cell Culture Media
Medical Supplements
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Albumedix
Merck
Ventria (InVitria)
NCPC
Oryzogen
HiMedia
Recombinant human serum albumin (rHSA) is genetically engineered and derived from a rice-based expression system. It is a highly purified and completely animal-, virus-, and bacteria-free product that was developed as an alternative to plasma-derived HSA, to which it is structurally equivalent.
Global Recombinant Human Serum Albumin key players include Albumedix, Merck, Ventria (InVitria), NCPC, Oryzogen, etc. Global top five manufacturers hold a revenue sales market share over 80%. Europe accounts for the most Market Share, which have a share over 45%, followed by North America. In terms of product, ScrHSA is the largest segment, with a share of 100% . And in terms of application, the largest application is Cell Culture Media, followed by Medical Supplements.
The global Recombinant Human Serum Albumin market was valued at US$ 65 million in 2020 and is expected to reach US$ 106.8 million by the end of 2027, growing at a CAGR of 7.3% during 2021-2027.
This report focuses on Recombinant Human Serum Albumin volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Recombinant Human Serum Albumin market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Recombinant Human Serum Albumin Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
OsrHSA
ScrHSA
Segment by Application
Cell Culture Media
Medical Supplements
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Albumedix
Merck
Ventria (InVitria)
NCPC
Oryzogen
HiMedia
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Request Sample
Request Discount
